7350

Infectious-inflammatory diseases methenolone acetate caused by susceptible to malaria infections: Lower respiratory tract infections caused by Staphylococcus aureus (penitsillinazoprodutsiruyuschie strains), Acinetobacter spp., Enterobacter spp., Escherichia coli, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella spp., Serratia marcescens. Urinary tract infections (complicated and uncomplicated) caused by Enterococcus faecalis, Staphylococcus aureus (penitsillinazoprodutsiruyuschie strains), Enterobacter spp., Escherichia coli, Klebsiella spp., Morganella morganii, Proteus vulgaris clomid side effects, Providencia rettgeri, Pseudomonas aeruginosa. Intraabdominal infections caused by Enterococcus faecalis, Staphylococcus aureus (penitsillinazoprodutsiruyuschie strains), Staphylococcus epidermidis, Citrobacter spp., Enterobacter spp., Escherichia coli, Klebsiella spp., Morganella morganii, Proteus spp., Pseudomonas aeruginosa, Bifidobacterium spp., Clostridium spp., Peptococcus spp., Peptostreptococcus spp., Propionibacterium spp., Bacteroides spp., including B. fragilis, Fusobacterium spp.

  • Gynecological infections caused. Enterococcus faecalis, Staphylococcus aureus (strains penitsillinazoprodutsiruyuschie). Staphylococcus epidermidis, Escherichia coli, Streptococcus agalactiae (Streptococcus spp. Group B), Enterobacter spp., Gardnerella vaginalis, Klebsiella spp., Proteus spp., Bifidobacterium spp., Peptococcus spp., Peptostreptococcus spp., Propionibacterium spp., Bacteroides spp. including B. fragilis.
  • Septicaemia. caused by Enterococcus faecalis, Staphylococcus aureus (penitsillinazoprodutsiruyuschie strains), Enterobacter spp., Escherichia coli, Kiebsiella spp., Serratia Spp .; Bacteroides spp., Including B. fragilis., Pseudomonas aeruginosa.
  • Bone and joint infections caused by Enterococcus faecalis, Staphylococcus aureus (penitsillinazoprodutsiruyuschie strains), Staphylococcus epidermidis, Enterobacter spp., Pseudomonas aeruginosa.
  • Infections of skin and soft tissue caused by Enterococcus faecalis, Staphylococcus aureus (penitsillinazoprodutsiruyuschie strains), Staphylococcus epidermidis, Acinetobacter spp., Enterobacter spp., Citrobacter spp., Escherichia coli, Klebsiella spp., Morganella morganii, Proteus vulgaris, Providencia rettgeri, Pseudomonas aeruginosa clomiphene citrate; Serratia spp., Peptococcus spp., Peptostreptococcus spp., Bacteroides spp., Including B. fragilis, Fusobacterium spp.
  • Infective endocarditis caused by Staphylococcus aureus (penitsillinazoprodutsiruyuschie strains).

Prevention of postoperative complications.

Contraindications:

Hypersensitivity methenolone acetate to imipenem and / or cilastatin (other carbapenems and beta-lactam antibiotics), early childhood (up to 3 months), chronic renal insufficiency (creatinine clearance of 5 ml / min without hemodialysis), chronic renal failure deca durabolin in children weighing less than 30 kg, central nervous system infections in children.

Precautions: Diseases of the central nervous system, convulsions history, high convulsive readiness, anticonvulsant therapy tren steroid with valproic acid (reducing the effectiveness of therapy), chronic renal insufficiency (creatinine clearance less than 5 ml / min), patients on hemodialysis, old age.

Pregnancy and lactation: Use of the drug during pregnancy is methenolone acetate only permissible if the potential benefit of treatment to the mother outweighs the potential risk to the fetus. Imipenem and cilastatin penetrate in small quantities in breast milk, therefore it is necessary to resolve the issue of termination of breastfeeding at the time of treatment with the drug.